Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
EU Project Advances Cancer Diagnostics via Liquid Biopsy
Imaging & Diagnostics EU Project Advances Cancer Diagnostics via Liquid Biopsy

The integration of next-generation sequencing into routine clinical practice represents a major leap forward for oncology, moving beyond invasive tissue extraction toward highly sensitive liquid biopsy techniques that monitor circulating tumor DNA in the bloodstream. The oncNGS project, reaching

How Is Remote Monitoring Transforming Modern Healthcare?
Digital Health How Is Remote Monitoring Transforming Modern Healthcare?

The traditional architecture of the medical system is experiencing a fundamental realignment as clinical expertise moves from sterile hospital wards into the intimate settings of residential living spaces. This profound transformation relies on Remote Patient Monitoring as its primary engine,

Is Your Health Data Safe With Generative AI Chatbots?
Regulatory & Compliance Is Your Health Data Safe With Generative AI Chatbots?

The rapid adoption of generative artificial intelligence has fundamentally altered how individuals seek medical clarity, with millions now bypassing traditional search engines to engage in deep, descriptive dialogues with chatbots regarding their most private health concerns. This shift is

Illinois Laws Shield Reproductive Privacy and Expand Access
Regulatory & Compliance Illinois Laws Shield Reproductive Privacy and Expand Access

The recent passage of House Bill 5295 and Senate Bill 3341 marks a transformative moment for Illinois as the state solidifies its legal infrastructure to protect reproductive freedoms and broaden healthcare access for residents and visitors alike. These measures represent a calculated response to

AI-Powered EHRs Are Modernizing Clinical Practice
Digital Health AI-Powered EHRs Are Modernizing Clinical Practice

Healthcare providers are currently witnessing a profound shift in how clinical data is managed as traditional electronic health records evolve from static repositories into dynamic digital assistants. For decades, the primary function of these systems centered on administrative oversight and

Can Mobile Tools Improve Screening for Cancer Survivors?
Digital Health Can Mobile Tools Improve Screening for Cancer Survivors?

For childhood cancer survivors who have already faced grueling treatments, the long-term risk of secondary malignancies like colorectal cancer represents a significant medical hurdle that requires lifelong vigilance. Despite clinical guidelines from the Children’s Oncology Group recommending

How Is Illinois Shielding Reproductive Privacy and Access?
Regulatory & Compliance How Is Illinois Shielding Reproductive Privacy and Access?

In the rapidly shifting landscape of American healthcare, Illinois has solidified its position as a critical sanctuary state for individuals seeking reproductive services amidst a complex web of conflicting regional regulations and digital surveillance concerns. As the national discourse remains

Remote Monitoring Ensures Reliable Patient Care This Winter
Digital Health Remote Monitoring Ensures Reliable Patient Care This Winter

Hospital emergency rooms often face a seasonal surge in admissions as temperatures drop and respiratory viruses begin to circulate more widely among the general population. The integration of high-fidelity remote monitoring systems has fundamentally changed how providers manage these seasonal

How Will Trump’s IDR Reforms Fix Medical Billing Disputes?
Digital Health How Will Trump’s IDR Reforms Fix Medical Billing Disputes?

The administrative friction once threatening to paralyze the American healthcare payment ecosystem has finally met its match in a sweeping regulatory overhaul that prioritizes operational precision over bureaucratic inertia. As the Trump administration finalizes the reforms for the Independent

Can J&J Fix the Fatal Software Error in Its Heart Pumps?
Infrastructure & Management Can J&J Fix the Fatal Software Error in Its Heart Pumps?

The recent surge in complex cardiac interventions has placed a massive spotlight on the mechanical assist devices that sustain life when the human heart falters during surgery. The acquisition of Abiomed for $16.6 billion signaled Johnson & Johnson’s aggressive expansion into high-growth medtech

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later